Metis Global Partners LLC Buys 109 Shares of The Cigna Group (NYSE:CI)

Metis Global Partners LLC lifted its stake in The Cigna Group (NYSE:CI) by 0.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,918 shares of the health services provider’s stock after buying an additional 109 shares during the quarter. Metis Global Partners LLC’s holdings in The Cigna Group were worth $3,291,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in CI. Collier Financial bought a new position in shares of The Cigna Group in the fourth quarter worth about $32,000. ORG Wealth Partners LLC purchased a new stake in shares of The Cigna Group during the fourth quarter worth about $34,000. Prospera Private Wealth LLC purchased a new stake in shares of The Cigna Group during the third quarter worth about $37,000. Compagnie Lombard Odier SCmA purchased a new stake in shares of The Cigna Group during the fourth quarter worth about $37,000. Finally, Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group during the third quarter worth about $45,000. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Price Performance

NYSE:CI opened at $308.66 on Friday. The firm has a market capitalization of $85.85 billion, a price-to-earnings ratio of 25.22, a PEG ratio of 0.98 and a beta of 0.54. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The business has a 50 day simple moving average of $289.54 and a 200-day simple moving average of $318.63. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the business earned $6.79 EPS. Equities analysts forecast that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date is Wednesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is currently 49.35%.

Wall Street Analyst Weigh In

CI has been the subject of several research analyst reports. Stephens cut their target price on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Morgan Stanley cut their price target on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Royal Bank of Canada set a $355.00 price target on The Cigna Group in a report on Friday, January 31st. Piper Sandler restated an “overweight” rating and set a $348.00 price target (down previously from $394.00) on shares of The Cigna Group in a report on Monday, February 3rd. Finally, Barclays cut their price target on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $372.31.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.